Clearside Biomedical, Inc. (CLSDQ) vs Oragenics, Inc. (OGEN)
Clearside Biomedical, Inc. and Oragenics, Inc. are both Biotechnology companies. Clearside Biomedical, Inc. and Oragenics, Inc. are of similar size ($2.3M and $2.2M). Clearside Biomedical, Inc. has negative trailing earnings, so its P/E is not meaningful; Oragenics, Inc. trades at 0.4×. Clearside Biomedical, Inc. grew revenue faster over the last twelve months: −56.8% against −75.1%. Oragenics, Inc. has the higher net margin (0.00% vs −780.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Oragenics, Inc. leads on 8 and Clearside Biomedical, Inc. on 7.
Valuation
Profitability
| Metric | CLSDQ | OGEN | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.55% | 19.89% | 65.16% |
| Operating margin | (689.76%) | 0.00% | 0.00% |
| Net margin | (780.93%) | 0.00% | 0.00% |
| Free cash flow margin | (653.23%) | 0.00% | 0.00% |
| Return on equity | 58.59% | (1,307.07%) | (57.72%) |
| Return on assets | (127.43%) | (264.23%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack